Target Name: ZMYM1
NCBI ID: G79830
Review Report on ZMYM1 Target / Biomarker Content of Review Report on ZMYM1 Target / Biomarker
ZMYM1
Other Name(s): Zinc finger, MYM domain containing 1 | Zinc finger MYM-type protein 1 (isoform a) | MYM | zinc finger, MYM-type 1 | zinc finger, MYM domain containing 1 | Zinc finger MYM-type protein 1 | ZMYM1_HUMAN | zinc finger MYM-type containing 1 | RP11-181E22.4 | Zinc finger MYM-type containing 1, transcript variant 5 | ZMYM1 variant 5

ZMYM1: A Potential Drug Target and Biomarker

Zinc finger proteins (ZFPs) are a family of transmembrane proteins that play a crucial role in various cellular processes, including gene regulation, DNA replication, and cell signaling. One of the well-known ZFPs is ZMYM1 (Zinc finger, MYM domain containing 1). This protein is a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

ZMYM1 is a 21-kDa protein that is expressed in various tissues and cells, including brain, heart, liver, and cancer cells. It is characterized by a N-terminal ZFN domain, a middle transmembrane region, and a C-terminalMYM domain. The ZMYM1 protein is involved in various cellular processes, including cell signaling, DNA replication, and gene regulation.

One of the unique features of ZMYM1 is its ability to interact with other proteins. It can form a complex with various transcription factors, including nuclear factor E2 (NFE2), which is known to play a role in gene regulation. Additionally, ZMYM1 can interact with DNA-binding proteins, such as histone modifications and non-coding RNAs (ncRNAs). This interaction between ZMYM1 and these proteins may regulate various cellular processes, including gene expression, DNA replication, and cell signaling.

ZMYM1 has also been shown to be involved in the regulation of cellular signaling pathways. For example, ZMYM1 has been shown to be involved in the regulation of the PI3K/Akt signaling pathway, which is involved in various cellular processes, including cell survival, proliferation, and angiogenesis. Additionally, ZMYM1 has been shown to be involved in the regulation of the TGF-β signaling pathway, which is involved in cell signaling, including cell growth, differentiation, and inflammation.

In terms of its potential as a drug target, ZMYM1 is an attractive target due to its involvement in various cellular processes that are implicated in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, ZMYM1 has been shown to be involved in the regulation of cell proliferation, angiogenesis, and survival, which are all potential targets for cancer therapies. Additionally, ZMYM1 has been shown to be involved in the regulation of cellular signaling pathways, which may be potential targets for neurodegenerative diseases.

In terms of its potential as a biomarker, ZMYM1 has been shown to be involved in various cellular processes that are associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, ZMYM1 has been shown to be involved in the regulation of cell proliferation, angiogenesis, and survival, which are all potential biomarkers for these diseases. Additionally, ZMYM1 has been shown to be involved in the regulation of cellular signaling pathways, which may be potential biomarkers for these diseases as well.

In conclusion, ZMYM1 is a protein that is involved in various cellular processes that are implicated in various diseases. Its ability to interact with other proteins and participate in cellular signaling pathways makes it an attractive target for drug development. Additionally, its involvement in the regulation of cellular processes that are associated with various diseases makes it a potential biomarker for these diseases. Further research is needed to fully understand the role of ZMYM1 in these processes and its potential as a drug target and biomarker.

Protein Name: Zinc Finger MYM-type Containing 1

The "ZMYM1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZMYM1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZMYM2 | ZMYM3 | ZMYM4 | ZMYM4-AS1 | ZMYM5 | ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134 | ZNF135 | ZNF136 | ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143 | ZNF146 | ZNF148 | ZNF154 | ZNF155 | ZNF157 | ZNF16 | ZNF160 | ZNF165 | ZNF169 | ZNF17 | ZNF174 | ZNF175 | ZNF177 | ZNF18 | ZNF180 | ZNF181 | ZNF182 | ZNF184 | ZNF185 | ZNF189 | ZNF19 | ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248